Complications of anaesthesia during pregnancy. Other complications of anaesthesia during pregnancy
Conditions
Interventions
Intervention 1: Remifentanil injection (0.05 microg /kg/h) intravenously, Duration of treatment: time from after clamping of umbilical cord to completion of surgery. Intervention 2: Fentanyl 2 microg/
Treatment - Drugs
Remifentanil injection (0.05 microg /kg/h) intravenously, Duration of treatment: time from after clamping of umbilical cord to completion of surgery
Fentanyl 2 microg/kg pulse morphin 0.1mg/kg intravenously, Duration of treatment: time from after clamping of umbilical cord to completion of surgery
Fentanyl injection (2 microg/kg/h) intravenously, Duration of treatment: time from after clamping of umbilical cord to completion of surgery
Sponsors
Medical School, Isfahan University of Medical Scienes,
Eligibility
Sex/Gender
Female
Age
16 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Parturients, ASA physical status I-II, scheduled for elective cesarean section, under general anesthesia Exclusion Criteria: Allergy to fentanyl or remifentanil, atopia, diabetes mellitus, presence of liver or kidney diseases, drugs abuse, presence of complicated pregnancy such as hypertension or preeclampsia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea intensity. Timepoint: at recovery, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual Analogous Scale (VAS) and scoring from 0 to 10.;Frequency of PONV. Timepoint: at recovery, 4, 8, 12 and 24 hours after surgery. Method of measurement: counting. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: at recovery, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual Analogous Scale (VAS) and scoring from 0 to 10.;Opioid consumption. Timepoint: at recovery, 4, 8, 12 and 24 hours after surgery. Method of measurement: in miligram of opioid.;Metoclopramide consumption. Timepoint: at recovery, 4, 8, 12 and 24 hours after surgery. Method of measurement: in miligram of drug. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mitra Jabalameli
Isfahan University of Medical Sciences
Outcome results
None listed